Unknown

Dataset Information

0

Long-term outcomes of two-stage, immediate and delayed breast reconstruction with polyurethane-covered versus textured implants: protocol of a prospective, multicentre randomised controlled trial (TIPI trial).


ABSTRACT:

Introduction

Two-stage implant-based breast reconstruction is the most commonly performed postmastectomy reconstructive technique. During the first stage, a tissue expander creates a sufficiently large pocket for the definite breast implant placed in the second stage. Capsular contracture is a common long-term complication associated with implant-based breast reconstruction, causing functional complaints and often requiring reoperation. The exact aetiology is still unknown, but a relationship between the outer surface of the implant and the probability of developing capsular contracture has been suggested. The purpose of this study is to determine whether polyurethane-covered implants result in a different capsular contracture rate than textured implants.

Methods and analysis

The Textured Implants versus Polyurethane-covered Implants (TIPI) trial is a multicentre randomised controlled trial with a 1:1 allocation rate and a follow-up of 10 years. A total of 321 breasts of female adults undergoing a two-stage breast reconstruction will be enrolled. The primary outcome is capsular contracture at 10-year follow-up which is graded with the modified Baker classification. It is analysed with survival analysis using a frailty model for clustered interval-censored data, with both an intention-to-treat and per-protocol approach. Secondary outcomes are other complication rates, surgical revision rate, patient satisfaction and quality of life and user-friendliness. Outcomes are measured 2 weeks, 6 months, 1, 2, 3, 5 and 10 years postoperatively. Interim analysis is performed when 1-year, 3-year and 5-year follow-up is completed.

Ethics and dissemination

The trial has been reviewed and approved by the Medical Research Ethics Committee of the Erasmus MC, University Medical Centre Rotterdam (MEC-2018-126) and locally by each participating centre. Written informed consent will be obtained from each study participant. The results will be disseminated by publication in peer-reviewed journals.

Trial registration

NTR7265.

SUBMITTER: Harmeling JX 

PROVIDER: S-EPMC8166604 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC9954288 | biostudies-literature
| S-EPMC6310612 | biostudies-literature
| S-EPMC10506123 | biostudies-literature
| S-EPMC10930935 | biostudies-literature
| S-EPMC3946018 | biostudies-other
| S-EPMC7292626 | biostudies-literature
| S-EPMC6112844 | biostudies-literature
| S-EPMC5560427 | biostudies-other
| S-EPMC9323042 | biostudies-literature
| S-EPMC9076787 | biostudies-literature